Compare GPMT & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GPMT | TXMD |
|---|---|---|
| Founded | 2015 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 64.7M | 23.3M |
| IPO Year | 2017 | 2012 |
| Metric | GPMT | TXMD |
|---|---|---|
| Price | $5.51 | $1.97 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $11.50 | N/A |
| AVG Volume (30 Days) | ★ 198.9K | 15.7K |
| Earning Date | 11-04-2026 | 11-11-2026 |
| Dividend Yield | ★ 6.94% | N/A |
| EPS Growth | 73.58 | ★ 73.68 |
| EPS | N/A | ★ 0.02 |
| Revenue | N/A | ★ $1,761,000.00 |
| Revenue This Year | $308.01 | $207.74 |
| Revenue Next Year | $8.50 | $2.15 |
| P/E Ratio | ★ N/A | $98.00 |
| Revenue Growth | N/A | ★ 35.25 |
| 52 Week Low | $0.74 | $1.03 |
| 52 Week High | $7.61 | $2.95 |
| Indicator | GPMT | TXMD |
|---|---|---|
| Relative Strength Index (RSI) | 69.41 | 39.58 |
| Support Level | $1.26 | $1.91 |
| Resistance Level | $7.61 | $2.15 |
| Average True Range (ATR) | 0.25 | 0.06 |
| MACD | 0.41 | -0.01 |
| Stochastic Oscillator | 68.99 | 11.76 |
Granite Point Mortgage Trust Inc focuses on directly originating, investing in, and managing senior floating rate commercial mortgage loans and other debt and debt-like commercial real estate investments. The company constructs its investment portfolio on a loan-by-loan basis, emphasizing rigorous credit underwriting, selectivity, and diversification, and assesses each investment from a fundamental value perspective relative to other opportunities available in the market. It typically provides intermediate-term bridge or transitional financing for a variety of purposes, including acquisitions, recapitalizations, refinancing, and a range of business plans, including lease-up, renovation, repositioning and repurposing of the commercial property.
TherapeuticsMD Inc is a pharmaceutical royalty company that owns and manages intellectual property, including trademarks and product rights, which are licensed to third-party pharmaceutical companies. The company generates revenue mainly through royalties and milestone payments from licensed products, including IMVEXXY, BIJUVA, and ANNOVERA, and does not directly manufacture or market pharmaceutical products.